Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of an Algorithm Designed to Predict the Recurrence of AF After Pulmonary Vein Isolation Using P-wave Duration and Procedural Unipolar Atrial Local Potential Measurements

NCT07471308 is registered in ClinicalTrials.gov with CathVision ApS as lead sponsor.

NCT NCT07471308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07471308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of an Algorithm Designed to Predict the Recurrence of AF After Pulmonary Vein Isolation Using P-wave Duration and Procedural Unipolar Atrial Local Potential Measurements
Lead sponsor
CathVision ApS
Phase
Observational
Overall status
Active, not recruiting
Start date
April 13, 2026
Completion date
September 15, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), atrial fibrillation (paroxysmal), atrial fibrillation patients treated with the farapulse™ pfa system, pulmonary vein isolation